Showing results (1-10 of 59) with videos related to
Sort By:
Pageof 6
Gastroenterology|January 1, 1994
Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?H S Merki, C H Wilder-SmithScandinavian Journal of Gastroenterology. Supplement|January 1, 1992
Tolerance during dosing with H2-receptor antagonists. An overviewC H Wilder-Smith, H S MerkiScandinavian Journal of Gastroenterology|May 1, 1991
Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482C H Wilder-Smith, H S MerkiDigestive Diseases and Sciences|December 1, 1991
Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcerC H Wilder-Smith, F Halter, H S MerkiGastroenterology|September 1, 1993
Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidineH S Merki, F Halter, C H Wilder-SmithBritish Journal of Clinical Pharmacology|January 1, 1995
Individual and group dose-responses to intravenous omeprazole in the first 24 h: pH-feedback-controlled and fixed-dose infusionsC H Wilder-Smith, H U Bettschen, H S MerkiBritish Journal of Clinical Pharmacology|May 1, 1992
pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responsesC H Wilder-Smith, F Halter, W Häcki, et al.Gastroenterology|September 1, 1991
The cephalic and gastric phases of gastric secretion during H2-antagonist treatmentH S Merki, C H Wilder-Smith, R P Walt, et al.Digestive Diseases and Sciences|November 1, 1993
Gastrospirillum hominis in asymptomatic, healthy individualsL Mazzucchelli, C H Wilder-Smith, C Ruchti, et al.Digestion|January 1, 1992
Is a fluoroscopic verification of the electrode position necessary in ambulatory intragastric pH monitoring?C H Wilder-Smith, M A Gennoni, J Triller, et al.Pageof 6